- Home
- SKYE vs RMTI Comparison
SKYE vs RMTI Comparison
Compare SKYE & RMTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SKYE
- RMTI
- Stock Information
- Founded
- SKYE 2012
- RMTI 1994
- Country
- SKYE United States
- RMTI United States
- Employees
- SKYE N/A
- RMTI N/A
- Industry
- SKYE Biotechnology: Pharmaceutical Preparations
- RMTI Biotechnology: Pharmaceutical Preparations
- Sector
- SKYE Health Care
- RMTI Health Care
- Exchange
- SKYE Nasdaq
- RMTI Nasdaq
- Market Cap
- SKYE 80.7M
- RMTI 71.1M
- IPO Year
- SKYE N/A
- RMTI 1998
- Fundamental
- Price
- SKYE $2.43
- RMTI $1.63
- Analyst Decision
- SKYE Buy
- RMTI Strong Buy
- Analyst Count
- SKYE 7
- RMTI 2
- Target Price
- SKYE $18.67
- RMTI $6.00
- AVG Volume (30 Days)
- SKYE 136.4K
- RMTI 199.1K
- Earning Date
- SKYE 03-21-2025
- RMTI 05-13-2025
- Dividend Yield
- SKYE N/A
- RMTI N/A
- EPS Growth
- SKYE N/A
- RMTI N/A
- EPS
- SKYE N/A
- RMTI N/A
- Revenue
- SKYE N/A
- RMTI $98,917,000.00
- Revenue This Year
- SKYE N/A
- RMTI $22.58
- Revenue Next Year
- SKYE N/A
- RMTI N/A
- P/E Ratio
- SKYE N/A
- RMTI N/A
- Revenue Growth
- SKYE N/A
- RMTI 22.37
- 52 Week Low
- SKYE $2.31
- RMTI $1.35
- 52 Week High
- SKYE $17.65
- RMTI $5.15
- Technical
- Relative Strength Index (RSI)
- SKYE 40.00
- RMTI 40.63
- Support Level
- SKYE $2.40
- RMTI $1.49
- Resistance Level
- SKYE $2.88
- RMTI $1.69
- Average True Range (ATR)
- SKYE 0.24
- RMTI 0.11
- MACD
- SKYE -0.02
- RMTI 0.01
- Stochastic Oscillator
- SKYE 3.74
- RMTI 46.67
About SKYE Skye Bioscience Inc. Common Stock
Skye Bioscience Inc is a pre-clinical pharmaceutical company located in San Diego, California. The company's clinical assets focus on the modulation of cannabinoid receptor 1 ("CB1") to provide novel treatments and alternatives for diseases caused by metabolic disorders, inflammation, fibrosis and neurodegeneration, such as obesity and glaucoma. The company's Phase 2 clinical candidates include nimacimab, a negative allosteric modulating antibody that inhibits peripheral CB1 receptors, currently being developed for the treatment of obesity and SBI-100 Ophthalmic Emulsion ("SBI-100 OE"), a CB1 agonist (activator), currently being developed for the treatment of glaucoma and ocular hypertension.
About RMTI Rockwell Medical Inc.
Rockwell Medical Inc is a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers. It is a supplier of liquid bicarbonate concentrates, and acid and dry bicarbonate concentrates for dialysis patients in the United States. The company's products include CitraPure citric acid concentrate, RenalPure liquid acid concentrate, and SteriLyte bicarbonate concentrate among others.